M
The startup has developed a diagnostic platform that analyzes bacterial responses to various antibiotics in multiple body fluids, including urine and blood. This technology enables healthcare providers to quickly identify the causative bacteria of urinary tract infections, reducing unnecessary antibiotic prescriptions and enhancing patient care.
Updated 3 months ago
Funding
$6.7M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Features
- The startup has developed a diagnostic platform that analyzes bacterial responses to various antibiotics in multiple body fluids, including urine and blood. This technology enables healthcare providers to quickly identify the causative bacteria of urinary tract infections, reducing unnecessary antibiotic prescriptions and enhancing patient care.